Diabetes patients who took clot-busting drugs had a lower risk of stroke-related disability than those who did not receive the treatment, according to a study in Neurology. Researchers studied 5,411 patients with diabetes and found that 43.2% of those who received clot-busting drugs had a modified Rankin Score of two or less, which corresponds to slight disability, compared with only 34.8% of those who did not take the drugs.
Clot-busting drugs improve stroke outcomes in diabetes patients
SmartBrief Job Listings for Health Care
|Senior Research Analyst||
America's Health Insurance Plans (AHIP)
|Manager, Regulatory Affairs||
|Washington DC, DC|
|Senior Counsel - FDA Regulatory Affairs||
|Director, Quality Assurance||
|Provider Relations Manager||
Breakthrough Behavioral, Inc.
|Redwood City, CA|